EnterpriseWorks Research Park is out of space and is working with Fox/Atkins on two new buildings scheduled to open in 2017 with a $13 million total investment anticipated. City incentives and development terms…
IllinoisVENTURES hosted an “Evening at Matter” event on December 7 along with UIC faculty, staff, the UIC Office of Technology Management, and corporate partners. UIC faculty and staff were invited to spend an…
Acetylon Pharmaceuticals today announced that it has entered into an agreement to be acquired by Celgene Corporation. Prior to the consummation of the acquisition, Acetylon will spin out a new company, Regenacy Pharmaceuticals,…
The University of Illinois System along with Mayor Emanuel, World Business Chicago, and Chicago Ideas Week hosted 200 top tech students from across the country from October 20-22 for ThinkChicago: Chicago Ideas Week.…
The Fall 2016 round of the Proof of Concept awards program led by IllinoisVENTURES, in partnership with OTM Chicago and supported by the UIC Chancellor’s Innovation Fund, is well underway. IllinoisVENTURES continues to…
A new, non-hormonal, vaginal gel contraceptive initially developed by Dr. Donald P Waller of UIC and Drs. Lourens Zaneveld and Robert Anderson of Rush University Medical Center has cleared phase III clinical trials,…